APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dexlansoprazole for Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dexlansoprazole for Injection Market Analysis and Forecast 2026-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchDexlansoprazole for Injection Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Dexlansoprazole for Injection Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Dexlansoprazole for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dexlansoprazole for Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dexlansoprazole for Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dexlansoprazole for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dexlansoprazole for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dexlansoprazole for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dexlansoprazole for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dexlansoprazole for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dexlansoprazole for Injection include Sailong Pharmaceutical, Jiangsu Aosaikang Pharmaceutical and Sunho Biologics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dexlansoprazole for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dexlansoprazole for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Dexlansoprazole for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dexlansoprazole for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dexlansoprazole for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dexlansoprazole for Injection sales, projected growth trends, production technology, application and end-user industry.

Dexlansoprazole for Injection Segment by Company

Sailong Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Sunho Biologics

Dexlansoprazole for Injection Segment by Type

Original Drug

Generic Drug

Dexlansoprazole for Injection Segment by Application

Hospital

Clinic

Others

Dexlansoprazole for Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dexlansoprazole for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dexlansoprazole for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dexlansoprazole for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dexlansoprazole for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dexlansoprazole for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dexlansoprazole for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dexlansoprazole for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Original Drug Major Manufacturers Table 3. Generic Drug Major Manufacturers Table 4. Global Dexlansoprazole for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Dexlansoprazole for Injection Industry Trends Table 9. Dexlansoprazole for Injection Industry Drivers Table 10. Dexlansoprazole for Injection Industry Opportunities and Challenges Table 11. Dexlansoprazole for Injection Industry Restraints Table 12. Global Dexlansoprazole for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Dexlansoprazole for Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Dexlansoprazole for Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Dexlansoprazole for Injection Revenue Market Share by Region (2021-2026) Table 16. Global Dexlansoprazole for Injection Revenue Market Share by Region (2027-2032) Table 17. Global Dexlansoprazole for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Dexlansoprazole for Injection Sales by Region (2021-2026) & (K Units) Table 19. Global Dexlansoprazole for Injection Sales by Region (2027-2032) & (K Units) Table 20. Global Dexlansoprazole for Injection Sales Market Share by Region (2021-2026) Table 21. Global Dexlansoprazole for Injection Sales Market Share by Region (2027-2032) Table 22. Global Dexlansoprazole for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Dexlansoprazole for Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Dexlansoprazole for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Dexlansoprazole for Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Dexlansoprazole for Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Dexlansoprazole for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Dexlansoprazole for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Dexlansoprazole for Injection Manufacturers, Product Type & Application Table 30. Global Dexlansoprazole for Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Dexlansoprazole for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Dexlansoprazole for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Dexlansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Dexlansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Dexlansoprazole for Injection Revenue Market Share by Type (2021-2026) Table 37. Global Dexlansoprazole for Injection Revenue Market Share by Type (2027-2032) Table 38. Global Dexlansoprazole for Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Dexlansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 40. Global Dexlansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 41. Global Dexlansoprazole for Injection Sales Market Share by Type (2021-2026) Table 42. Global Dexlansoprazole for Injection Sales Market Share by Type (2027-2032) Table 43. Global Dexlansoprazole for Injection Price by Type (2021-2026) & (US$/Unit) Table 44. Global Dexlansoprazole for Injection Price by Type (2027-2032) & (US$/Unit) Table 45. Global Dexlansoprazole for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Dexlansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Dexlansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Dexlansoprazole for Injection Revenue Market Share by Application (2021-2026) Table 49. Global Dexlansoprazole for Injection Revenue Market Share by Application (2027-2032) Table 50. Global Dexlansoprazole for Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Dexlansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 52. Global Dexlansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 53. Global Dexlansoprazole for Injection Sales Market Share by Application (2021-2026) Table 54. Global Dexlansoprazole for Injection Sales Market Share by Application (2027-2032) Table 55. Global Dexlansoprazole for Injection Price by Application (2021-2026) & (US$/Unit) Table 56. Global Dexlansoprazole for Injection Price by Application (2027-2032) & (US$/Unit) Table 57. Sailong Pharmaceutical Company Information Table 58. Sailong Pharmaceutical Business Overview Table 59. Sailong Pharmaceutical Dexlansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Sailong Pharmaceutical Dexlansoprazole for Injection Product Portfolio Table 61. Sailong Pharmaceutical Recent Development Table 62. Jiangsu Aosaikang Pharmaceutical Company Information Table 63. Jiangsu Aosaikang Pharmaceutical Business Overview Table 64. Jiangsu Aosaikang Pharmaceutical Dexlansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Jiangsu Aosaikang Pharmaceutical Dexlansoprazole for Injection Product Portfolio Table 66. Jiangsu Aosaikang Pharmaceutical Recent Development Table 67. Sunho Biologics Company Information Table 68. Sunho Biologics Business Overview Table 69. Sunho Biologics Dexlansoprazole for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Sunho Biologics Dexlansoprazole for Injection Product Portfolio Table 71. Sunho Biologics Recent Development Table 72. North America Dexlansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Dexlansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Dexlansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 75. North America Dexlansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 76. North America Dexlansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America Dexlansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America Dexlansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Dexlansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Dexlansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 81. North America Dexlansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 82. North America Dexlansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America Dexlansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America Dexlansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Dexlansoprazole for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Dexlansoprazole for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Dexlansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America Dexlansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 89. North America Dexlansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 90. North America Dexlansoprazole for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America Dexlansoprazole for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 93. Canada Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 94. Europe Dexlansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Dexlansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Dexlansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 97. Europe Dexlansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 98. Europe Dexlansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 99. Europe Dexlansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 100. Europe Dexlansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Dexlansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Dexlansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 103. Europe Dexlansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 104. Europe Dexlansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 105. Europe Dexlansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 106. Europe Dexlansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Dexlansoprazole for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. Europe Dexlansoprazole for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. Europe Dexlansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 110. Europe Dexlansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 111. Europe Dexlansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 112. Europe Dexlansoprazole for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 113. Europe Dexlansoprazole for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 114. Germany Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 115. France Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 116. U.K. Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 117. Italy Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 118. Netherlands Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 119. China Dexlansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 120. China Dexlansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 121. China Dexlansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 122. China Dexlansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 123. China Dexlansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 124. China Dexlansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 125. China Dexlansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 126. China Dexlansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 127. China Dexlansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 128. China Dexlansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 129. China Dexlansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 130. China Dexlansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Asia Dexlansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 132. Asia Dexlansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 133. Asia Dexlansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 134. Asia Dexlansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 135. Asia Dexlansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 136. Asia Dexlansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 137. Asia Dexlansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Dexlansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Dexlansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 140. Asia Dexlansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 141. Asia Dexlansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 142. Asia Dexlansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 143. Asia Dexlansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Dexlansoprazole for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Asia Dexlansoprazole for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Asia Dexlansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. Asia Dexlansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 148. Asia Dexlansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 149. Asia Dexlansoprazole for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 150. Asia Dexlansoprazole for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 151. Japan Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 152. South Korea Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 153. India Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 154. Australia Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 155. China Taiwan Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 156. Southeast Asia Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 157. SAMEA Dexlansoprazole for Injection Revenue by Type (2021-2026) & (US$ Million) Table 158. SAMEA Dexlansoprazole for Injection Revenue by Type (2027-2032) & (US$ Million) Table 159. SAMEA Dexlansoprazole for Injection Sales by Type (2021-2026) & (K Units) Table 160. SAMEA Dexlansoprazole for Injection Sales by Type (2027-2032) & (K Units) Table 161. SAMEA Dexlansoprazole for Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 162. SAMEA Dexlansoprazole for Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 163. SAMEA Dexlansoprazole for Injection Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Dexlansoprazole for Injection Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Dexlansoprazole for Injection Sales by Application (2021-2026) & (K Units) Table 166. SAMEA Dexlansoprazole for Injection Sales by Application (2027-2032) & (K Units) Table 167. SAMEA Dexlansoprazole for Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 168. SAMEA Dexlansoprazole for Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 169. SAMEA Dexlansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. SAMEA Dexlansoprazole for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. SAMEA Dexlansoprazole for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. SAMEA Dexlansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. SAMEA Dexlansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 174. SAMEA Dexlansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 175. SAMEA Dexlansoprazole for Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 176. SAMEA Dexlansoprazole for Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Brazil Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 178. Argentina Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 179. Chile Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 180. Colombia Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 181. Peru Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 182. Saudi Arabia Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 183. Israel Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 184. UAE Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 185. Turkey Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 186. Iran Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 187. Egypt Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Dexlansoprazole for Injection Distributors List Table 191. Dexlansoprazole for Injection Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Dexlansoprazole for Injection Image Figure 2. Global Dexlansoprazole for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dexlansoprazole for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. Original Drug Image Figure 5. Generic Drug Image Figure 6. Global Dexlansoprazole for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Dexlansoprazole for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Dexlansoprazole for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dexlansoprazole for Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Dexlansoprazole for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Dexlansoprazole for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Dexlansoprazole for Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Dexlansoprazole for Injection Sales (2021-2032) & (K Units) Figure 17. Global Dexlansoprazole for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Dexlansoprazole for Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Dexlansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 20. Europe Dexlansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 21. China Dexlansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Dexlansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Dexlansoprazole for Injection Sales YoY (2021-2032) & (K Units) Figure 24. Global Dexlansoprazole for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Dexlansoprazole for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Dexlansoprazole for Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Dexlansoprazole for Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Dexlansoprazole for Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Dexlansoprazole for Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Dexlansoprazole for Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dexlansoprazole for Injection Sales Market Share by Type (2021-2032) Figure 33. Global Dexlansoprazole for Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Dexlansoprazole for Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Dexlansoprazole for Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Dexlansoprazole for Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Dexlansoprazole for Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dexlansoprazole for Injection Sales Market Share by Application (2021-2032) Figure 39. North America Dexlansoprazole for Injection Revenue Share by Type (2021-2032) Figure 40. North America Dexlansoprazole for Injection Sales Share by Type (2021-2032) Figure 41. North America Dexlansoprazole for Injection Revenue Share by Application (2021-2032) Figure 42. North America Dexlansoprazole for Injection Sales Share by Application (2021-2032) Figure 43. North America Dexlansoprazole for Injection Revenue Share by Country (2021-2032) Figure 44. North America Dexlansoprazole for Injection Sales Share by Country (2021-2032) Figure 45. Europe Dexlansoprazole for Injection Revenue Share by Type (2021-2032) Figure 46. Europe Dexlansoprazole for Injection Sales Share by Type (2021-2032) Figure 47. Europe Dexlansoprazole for Injection Revenue Share by Application (2021-2032) Figure 48. Europe Dexlansoprazole for Injection Sales Share by Application (2021-2032) Figure 49. Europe Dexlansoprazole for Injection Revenue Share by Country (2021-2032) Figure 50. Europe Dexlansoprazole for Injection Sales Share by Country (2021-2032) Figure 51. China Dexlansoprazole for Injection Revenue Share by Type (2021-2032) Figure 52. China Dexlansoprazole for Injection Sales Share by Type (2021-2032) Figure 53. China Dexlansoprazole for Injection Revenue Share by Application (2021-2032) Figure 54. China Dexlansoprazole for Injection Sales Share by Application (2021-2032) Figure 55. Asia Dexlansoprazole for Injection Revenue Share by Type (2021-2032) Figure 56. Asia Dexlansoprazole for Injection Sales Share by Type (2021-2032) Figure 57. Asia Dexlansoprazole for Injection Revenue Share by Application (2021-2032) Figure 58. Asia Dexlansoprazole for Injection Sales Share by Application (2021-2032) Figure 59. Asia Dexlansoprazole for Injection Revenue Share by Country (2021-2032) Figure 60. Asia Dexlansoprazole for Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Dexlansoprazole for Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Dexlansoprazole for Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Dexlansoprazole for Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Dexlansoprazole for Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Dexlansoprazole for Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Dexlansoprazole for Injection Sales Share by Country (2021-2032) Figure 67. Dexlansoprazole for Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Dexlansoprazole for Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sailong Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Sunho Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dexlansoprazole for Injection Market by Type
  3. 1.2.1 Global Dexlansoprazole for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Original Drug
  5. 1.2.3 Generic Drug
  6. 1.3 Dexlansoprazole for Injection Market by Application
  7. 1.3.1 Global Dexlansoprazole for Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Dexlansoprazole for Injection Market Dynamics
  1. 2.1 Dexlansoprazole for Injection Industry Trends
  2. 2.2 Dexlansoprazole for Injection Industry Drivers
  3. 2.3 Dexlansoprazole for Injection Industry Opportunities and Challenges
  4. 2.4 Dexlansoprazole for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dexlansoprazole for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dexlansoprazole for Injection Revenue by Region
  3. 3.2.1 Global Dexlansoprazole for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dexlansoprazole for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Dexlansoprazole for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Dexlansoprazole for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dexlansoprazole for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dexlansoprazole for Injection Sales by Region
  9. 3.4.1 Global Dexlansoprazole for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dexlansoprazole for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Dexlansoprazole for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Dexlansoprazole for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dexlansoprazole for Injection Revenue by Manufacturers
  2. 4.1.1 Global Dexlansoprazole for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dexlansoprazole for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dexlansoprazole for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dexlansoprazole for Injection Sales by Manufacturers
  6. 4.2.1 Global Dexlansoprazole for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dexlansoprazole for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dexlansoprazole for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dexlansoprazole for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dexlansoprazole for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dexlansoprazole for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dexlansoprazole for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Dexlansoprazole for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dexlansoprazole for Injection Market CR5 and HHI
  16. 4.8.2 2025 Dexlansoprazole for Injection Tier 1, Tier 2, and Tier 3
5 Dexlansoprazole for Injection Market by Type
  1. 5.1 Global Dexlansoprazole for Injection Revenue by Type
  2. 5.1.1 Global Dexlansoprazole for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dexlansoprazole for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dexlansoprazole for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dexlansoprazole for Injection Sales by Type
  6. 5.2.1 Global Dexlansoprazole for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dexlansoprazole for Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Dexlansoprazole for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dexlansoprazole for Injection Price by Type
6 Dexlansoprazole for Injection Market by Application
  1. 6.1 Global Dexlansoprazole for Injection Revenue by Application
  2. 6.1.1 Global Dexlansoprazole for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dexlansoprazole for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dexlansoprazole for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dexlansoprazole for Injection Sales by Application
  6. 6.2.1 Global Dexlansoprazole for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dexlansoprazole for Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Dexlansoprazole for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dexlansoprazole for Injection Price by Application
7 Company Profiles
  1. 7.1 Sailong Pharmaceutical
  2. 7.1.1 Sailong Pharmaceutical Company Information
  3. 7.1.2 Sailong Pharmaceutical Business Overview
  4. 7.1.3 Sailong Pharmaceutical Dexlansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sailong Pharmaceutical Dexlansoprazole for Injection Product Portfolio
  6. 7.1.5 Sailong Pharmaceutical Recent Developments
  7. 7.2 Jiangsu Aosaikang Pharmaceutical
  8. 7.2.1 Jiangsu Aosaikang Pharmaceutical Company Information
  9. 7.2.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  10. 7.2.3 Jiangsu Aosaikang Pharmaceutical Dexlansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Aosaikang Pharmaceutical Dexlansoprazole for Injection Product Portfolio
  12. 7.2.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  13. 7.3 Sunho Biologics
  14. 7.3.1 Sunho Biologics Company Information
  15. 7.3.2 Sunho Biologics Business Overview
  16. 7.3.3 Sunho Biologics Dexlansoprazole for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sunho Biologics Dexlansoprazole for Injection Product Portfolio
  18. 7.3.5 Sunho Biologics Recent Developments
8 North America
  1. 8.1 North America Dexlansoprazole for Injection Market Size by Type
  2. 8.1.1 North America Dexlansoprazole for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Dexlansoprazole for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Dexlansoprazole for Injection Price by Type (2021-2032)
  5. 8.2 North America Dexlansoprazole for Injection Market Size by Application
  6. 8.2.1 North America Dexlansoprazole for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Dexlansoprazole for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Dexlansoprazole for Injection Price by Application (2021-2032)
  9. 8.3 North America Dexlansoprazole for Injection Market Size by Country
  10. 8.3.1 North America Dexlansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dexlansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dexlansoprazole for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Dexlansoprazole for Injection Market Size by Type
  2. 9.1.1 Europe Dexlansoprazole for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dexlansoprazole for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Dexlansoprazole for Injection Price by Type (2021-2032)
  5. 9.2 Europe Dexlansoprazole for Injection Market Size by Application
  6. 9.2.1 Europe Dexlansoprazole for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dexlansoprazole for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Dexlansoprazole for Injection Price by Application (2021-2032)
  9. 9.3 Europe Dexlansoprazole for Injection Market Size by Country
  10. 9.3.1 Europe Dexlansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dexlansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dexlansoprazole for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Dexlansoprazole for Injection Market Size by Type
  2. 10.1.1 China Dexlansoprazole for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Dexlansoprazole for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Dexlansoprazole for Injection Price by Type (2021-2032)
  5. 10.2 China Dexlansoprazole for Injection Market Size by Application
  6. 10.2.1 China Dexlansoprazole for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Dexlansoprazole for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Dexlansoprazole for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dexlansoprazole for Injection Market Size by Type
  2. 11.1.1 Asia Dexlansoprazole for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dexlansoprazole for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Dexlansoprazole for Injection Price by Type (2021-2032)
  5. 11.2 Asia Dexlansoprazole for Injection Market Size by Application
  6. 11.2.1 Asia Dexlansoprazole for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dexlansoprazole for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Dexlansoprazole for Injection Price by Application (2021-2032)
  9. 11.3 Asia Dexlansoprazole for Injection Market Size by Country
  10. 11.3.1 Asia Dexlansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dexlansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dexlansoprazole for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dexlansoprazole for Injection Market Size by Type
  2. 12.1.1 SAMEA Dexlansoprazole for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dexlansoprazole for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dexlansoprazole for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Dexlansoprazole for Injection Market Size by Application
  6. 12.2.1 SAMEA Dexlansoprazole for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dexlansoprazole for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dexlansoprazole for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Dexlansoprazole for Injection Market Size by Country
  10. 12.3.1 SAMEA Dexlansoprazole for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dexlansoprazole for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dexlansoprazole for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dexlansoprazole for Injection Value Chain Analysis
  2. 13.1.1 Dexlansoprazole for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dexlansoprazole for Injection Production Mode & Process
  6. 13.2 Dexlansoprazole for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dexlansoprazole for Injection Distributors
  9. 13.2.3 Dexlansoprazole for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst